Palvella Therapeutics (PVLA) Net Margin Growth (1y) (2015 - 2024)
Palvella Therapeutics (PVLA) Net Margin Growth (1y) (2015 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Palvella Therapeutics |
1.49 Bn |
1.23 Bn |
- |
- |
| Date | Value |
| Mar 31, 2024 |
-436,820.00 |
| Sep 30, 2023 |
455,056.00 |
| Jun 30, 2023 |
36,446.00 |
| Mar 31, 2023 |
-71,486.00 |
| Sep 30, 2022 |
-393,986.00 |
| Jun 30, 2022 |
30,803.00 |
| Mar 31, 2022 |
-2,900.00 |
| Dec 31, 2021 |
43,914.00 |
| Sep 30, 2021 |
-24,258.00 |
| Jun 30, 2021 |
-61,952.00 |
| Mar 31, 2021 |
-1,222.00 |
| Dec 31, 2020 |
-63,556.00 |
| Sep 30, 2020 |
-42,329.00 |
| Jun 30, 2020 |
18,027.00 |
| Mar 31, 2020 |
9,443.00 |
| Dec 31, 2019 |
192,177.00 |
| Sep 30, 2019 |
5,660.00 |
| Jun 30, 2019 |
-21,878.00 |
| Mar 31, 2019 |
8,877.00 |
| Dec 31, 2018 |
-198,827.00 |